Skip to main content
AstraZeneca PLC logo

AstraZeneca PLC — Investor Relations & Filings

Ticker · AZN ISIN · GB0009895292 LEI · PY6ZZQWO2IZFZC3IOL08 IL Manufacturing
Open in API
Filings indexed 3,405 across all filing types
Latest filing 2018-04-24 Capital/Financing Update
Country GB United Kingdom
Listing IL AZN

About AstraZeneca PLC

https://www.astrazeneca.com/

AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company's portfolio is concentrated on several main therapy areas, including Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. AstraZeneca is committed to advancing healthcare through a robust research and development pipeline, aiming to deliver innovative medicines that address significant unmet medical needs for millions of patients worldwide. The company leverages scientific innovation to transform the future of healthcare and improve patient outcomes.

Recent filings

Filing Released Lang Actions
Issue of Equity - AstraZeneca
Capital/Financing Update Classification · 95% confidence The document begins with an 'RNS Number' and is dated April 24, 2018. The content details a significant corporate action: AstraZeneca subscribing for additional shares in Circassia Pharmaceuticals Plc and an amendment to a development and commercialization agreement (DCA). This involves changes in shareholding, capital structure (subscription for New Shares), and future financing arrangements. Since this is a formal announcement of a material corporate event released via the RNS system (London Stock Exchange's news service), and it specifically deals with share issuance/capital changes related to a transaction, it fits best under Capital/Financing Update (CAP) or potentially a general Regulatory Filing (RNS). However, the core subject is the agreement to subscribe for new shares and amend financing terms, which strongly aligns with 'Capital/Financing Update' (CAP). Given the nature of the announcement (share subscription, equity threshold, loan facility changes), CAP is the most specific fit, although RNS is also applicable as it is an RNS release.
2018-04-24 English
6-K Filing
Regulatory Filings
2018-04-24 English
FDA approves Tagrisso for 1st-line use in NSCLC
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and a date, indicating it is a regulatory announcement disseminated via the Regulatory News Service (RNS). The content is a press release announcing a significant event: the US FDA approval of a drug (Tagrisso) for a specific cancer treatment indication. This type of material—a corporate announcement of a major regulatory or business development—is typically classified as a general regulatory filing or announcement, especially when it is not a full financial report (like 10-K or IR) or a specific management/governance document. Since it is a broad regulatory announcement that doesn't fit the more specific categories (like DIV, MANG, or ER), the most appropriate fallback is RNS (Regulatory Filings). The document length (10117 chars) is substantial, but its structure is that of a press release/announcement, not a comprehensive statutory report.
2018-04-19 English
6-K Filing
Regulatory Filings
2018-04-19 English
Notice of AGM
AGM Information Classification · 98% confidence The document explicitly states 'NOTICE OF ANNUAL GENERAL MEETING' and mentions the 'Notice of Annual General Meeting 2018 and Shareholders' Circular (the Notice)'. It also provides the date, time, and location for the AGM. Although it mentions the AGM Notice, the core subject is the meeting itself, which aligns best with AGM Information (AGM-R). It is not the proxy statement (PSI) or the voting results (DVA), but the announcement related to the meeting event. Given the direct reference to the AGM notice and details, AGM-R is the most appropriate classification.
2018-04-13 English
6-K Filing
Regulatory Filings
2018-04-13 English

Browse filings by year

34 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.